Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies
Authors:
- Jue HouJHJue Hou
- Rachel ZhaoRZRachel Zhao
- Jessica GronsbellJGJessica Gronsbell
- Yucong LinYLYucong Lin
- Clara-Lea BonzelCBClara-Lea Bonzel
- Qingyi ZengQZQingyi Zeng
- Sinian ZhangSZSinian Zhang
- Brett K Beaulieu-JonesBBBrett K Beaulieu-Jones
- Griffin M WeberGWGriffin M Weber
- Thomas JemielitaTJThomas Jemielita
- Shuyan Sabrina WanSWShuyan Sabrina Wan
- Chuan HongCHChuan Hong
Open Access
- 25 May 2023
- journal article
- research article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25 (1) , e45662
Abstract
Although randomized controlled trials (RCTs) are the gold standard for establishing the efficacy and safety of a medical treatment, real-world evidence (RWE) generated from real-world data has been vital in postapproval monitoring and is being promoted for the regulatory process of experimental therapies. An emerging source of real-world data is electronic health records (EHRs), which contain detailed information on patient care in both structured (eg, diagnosis codes) and unstructured (eg, clinical notes and images) forms. Despite the granularity of the data available in EHRs, the critical variables required to reliably assess the relationship between a treatment and clinical outcome are challenging to extract. To address this fundamental challenge and accelerate the reliable use of EHRs for RWE, we introduce an integrated data curation and modeling pipeline consisting of 4 modules that leverage recent advances in natural language processing, computational phenotyping, and causal modeling techniques with noisy data. Module 1 consists of techniques for data harmonization. We use natural language processing to recognize clinical variables from RCT design documents and map the extracted variables to EHR features with description matching and knowledge networks. Module 2 then develops techniques for cohort construction using advanced phenotyping algorithms to both identify patients with diseases of interest and define the treatment arms. Module 3 introduces methods for variable curation, including a list of existing tools to extract baseline variables from different sources (eg, codified, free text, and medical imaging) and end points of various types (eg, death, binary, temporal, and numerical). Finally, module 4 presents validation and robust modeling methods, and we propose a strategy to create gold-standard labels for EHR variables of interest to validate data curation quality and perform subsequent causal modeling for RWE. In addition to the workflow proposed in our pipeline, we also develop a reporting guideline for RWE that covers the necessary information to facilitate transparent reporting and reproducibility of results. Moreover, our pipeline is highly data driven, enhancing study data with a rich variety of publicly available information and knowledge sources. We also showcase our pipeline and provide guidance on the deployment of relevant tools by revisiting the emulation of the Clinical Outcomes of Surgical Therapy Study Group Trial on laparoscopy-assisted colectomy versus open colectomy in patients with early-stage colon cancer. We also draw on existing literature on EHR emulation of RCTs together with our own studies with the Mass General Brigham EHR.Keywords
All Related Versions
This publication has 97 references indexed in Scilit:
- Portability of an algorithm to identify rheumatoid arthritis in electronic health recordsJournal of the American Medical Informatics Association, 2012
- Validation of a common data model for active safety surveillance researchJournal of the American Medical Informatics Association, 2012
- PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associationsBioinformatics, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE StudyJournal of Clinical Oncology, 2008
- The Adaptive Lasso and Its Oracle PropertiesJournal of the American Statistical Association, 2006
- Challenges of Using Medical Insurance Claims Data for Utilization AnalysisAmerican Journal of Medical Quality, 2006
- Model Selection and Estimation in Regression with Grouped VariablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 2005
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- A Comparison of Laparoscopically Assisted and Open Colectomy for Colon CancerNew England Journal of Medicine, 2004